
Technical analysis of Gilead Sciences, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes medicines in areas of unmet medical need. The company offers medications for the treatment of HIV-1 infection, chronic hepatitis C virus, chronic hepatitis B virus, and primary biliary cholangitis, as well as CAR T-cell therapies and immunotherapies for cancer patients. Gilead maintains collaboration agreements with various organizations for research and development of new treatments.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the GILD analysis.
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
How is Gilead Sciences, Inc. analysed technically?
Technical analysis of Gilead Sciences, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Gilead Sciences, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Gilead Sciences, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Gilead Sciences, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.